Picture of Solvonis Therapeutics logo

SVNS Solvonis Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Graft Polymer Says Filing Of US Provisional Patent For Substance Use Disorders Treatment

May 28 (Reuters) - Graft Polymer (UK) Plc  GPL.L :
    * FILING OF US PROVISIONAL PATENT FOR SUBSTANCE USE
DISORDERS
TREATMENT

Source text for Eikon:  ID:nRSb9341Pa 
Further company coverage:  GPL.L 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Solvonis Therapeutics

See all news